Bernhard R. M. Ehmer

Bernhard R.
M.
Ehmer is currently the Chairman-Supervisory Board at Biotest AG, an Independent Non-Executive Director at Achilles Therapeutics Plc, an Independent Member-Supervisory Board at Affimed NV, and a Member-Supervisory Board at Affimed GmbH.
Previously, he held positions such as Chief Executive Officer & Managing Director at Biopheresis GmbH and BioPheresis Technologies, Inc., President & Chief Executive Officer at Neovii Biotech GmbH, Chairman-Management Board at Biotest AG, Chairman at Symphogen A, Director at ADMA Biologics, Inc., Director at Aton SA, Managing Director & Senior Vice President at ImClone Systems International GmbH, VP, Head-Strategic Planning & Alliance Management at Merck KGaA, Head-Clinical Research & Development Operations at Merck KGaA, and Head-Therapeutics & Medical Operations at Boehringer Mannheim GmbH.
He also served as President at ImClone Systems Corp.
Dr. Ehmer obtained his undergraduate degree from Ruprecht-Karls-Universität Heidelberg and Ludwig-Maximilians-Universität München in 1982.